EN | FR | DE

They already use Binocs

A game- changing market

With 900 advanced therapies currently under investigation and an expected 10 to 20 new therapy approvals each year from 2025 onwards, cell & gene therapy is going fast. But, it brings its own set of unique challenges to adapt.

one-patient batch

… it’s a mind shift in terms of how to organize the production process.

Disintegrated supply chain

…from patient journey platforms to the production shopfloor: there’s a lack of integration.

every slot counts

…optimizing capacity utilization is more important than ever, especially as there is a lack of capacity and every product slot counts

High variability

… as the supply chain has a lot of moving parts, which are hard to predict.

How Binocs can help:

“Binocs is in pole position in ex-vivo CGT / advanced therapies with an installed base in both commercial and clinical production. Currently, there are 4 commercial production CGT sites that already use Binocs today and 6 leading CGT manufacturers that are evaluating Binocs as their supply chain end-to-end planning solution.”

End- to- end integration

  • Patient journey platforms (Trakcel, Vineti, in-house platforms, …) continuously & automatically synchronized with Binocs.
  • Seamless integration between Binocs & the production shopfloor (LIMS, ERP, AMS, …).

Dynamic site and slot allocation

  • Automatic site & slot allocation, based on configurable assignment rules, optimizing utilization rates.
  • Dynamic optimization as it continuously synchronizes with patient Journey Platforms, treatment centres (CRA) and the rest of the supply chain.

Projected slot capacity management

  • Get visibility on what you project as available capacity in (slots/day) for patients’ batches.
  • Handle exceptions better (cancellations, non-availabilities, holidays).
  • Utilize backup slots when needed.
  • An algorithmic projection you can trust (<> manual).

Automatic scheduling

  • Automatic day-to-day scheduling across all teams.
  • The digital schedule board makes your planning transparent & easy to distribute to your teams.
  • Re-shuffle the schedule in real-time to deal with changes in the planning.

End- to- end visibility

  • Track progress & get real-time visibility across your different patient batches.
  • Track individual patient batches and ACT.

Operating model management

  • Incoming patient batches automatically translated into sequenced and integrated production steps, QC operations, …
  • Easily scalable: from scheduling one team, to scheduling a multi-site supply chain.
  • Configure the rules and applicable constraints to calculate “Capable-to-promise”.

Need more convincing? No problem!
Request your demo and get access right away.

One connected plan

  • Connected planning horizons: detailed scheduling and capacity planning
  • Connected teams, across the globe
  • In sync with your LIMS and Supply Chain Planning

Zero input

  • Teach the machine how you work
  • Map testing and non-testing activities to obtain the full picture

Immediate insights

  • Find the capacity root causes at a glance, but…
  • Also find the solutions in the blink of an eye

Forward looking KPIs

  • A balanced set of KPIs to drive your performance
  • Unleash your performance dashboards

Take their word for it

  • Regulatory Affairs is an important part of the R&D delivery chain. I’m amazed at how Binocs moved it to a higher operational and planning maturity in such a short timeframe.

    - SVP R&D, Global Pharma player

  • I have clear visibility on status and upcoming writing tasks. Better planning gives more focus to the team members and increases productivity.

    - RA CMC Manager, Global Pharma player

  • Binocs connects with different RIMS sources and generates cross-team work sequences for over a thousand submissions twice a week. That’s a huge timesaver on input and a massive improvement to align our way of working

    - Regulatory Operations Director, Global Pharma player

  • Binocs uses machine learning and data science methods to tune the business operating model and workload estimates. That’s unique in its kind.

    - CIO of a global pharmaceutical company

  • Binocs really helps me to give a stronger ‘YES’ to my management

    - R&D Director of a food and beverages company

Blogs & cases from the field

With the past year seeing Kite Therapeutics and Novartis make headlines for their groundbreaking therapeutic approvals, and a host of innovative biotech companies quickly advancing their production towards commercialization, the Cell and Gene industry is rapidly transforming the standard of care for rare diseases and......

Cell gene therapy (CGT) and Cell culture development have quite a fixed and sequenced way of process execution. Different people and equipment need to be aligned along this process. But when multiple batches need to be produced, planning the people and equipment becomes quite the......

We’re here for you

Curious to know what Binocs can do for you? A 30 or 90 minute demo is the best way to find out!

Or just send us an e-mail using the form below. You’ll hear from us asap!

Contact Binocs- send an email, pop in for a coffee in the office, or just give us a call +322 66 99 111